Randomised controlled trial (RCT) of community management of deep venous thrombosis (DVT) using low molecular weight heparin versus hospital care

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN25452470

Enrollment

484

Registered

2004-01-23

Start date

2000-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular diseases: Thromboembolic disease Circulatory System Deep vein thrombosis

Interventions

1. Intervention patients will either be discharged from A&E following confirmation of diagnosis having been given the first dose of low-molecular weight heparin (LMWH) and warfarin, or prior to confir

Eligibility

Inclusion criteria

Inclusion criteria: All patients aged 18 or over presenting to the A&E Department of the City Hospital, Birmingham, with a clinical diagnosis of Deep Venous Thrombosis (DVT) will be eligible for entry into the study. Patients will be randomised to either an intervention or control arm of the study. 484 patients will be recruited. Assuming a radiological positive diagnosis rate of 50% this will leave 121 patients in each arm of the study.

Exclusion criteria

Exclusion criteria: Patients who need to be admitted to hospital for concomitant reasons, patients requiring venography, pregnant and breast feeding women and patients with concurrent malignancy will be excluded.

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026